Bicarbonate for In-Hospital Cardiac Arrest

Phase 4
Recruiting
Conditions
Interventions
Registration Number
NCT05564130
Lead Sponsor
Lars Wiuff Andersen
Brief Summary

This is an investigator-initiated, multicenter, randomized, placebo-controlled, parallel group, double-blind, superiority trial of sodium bicarbonate during adult in-hospital cardiac arrest. There will be 22 enrolling sites in Denmark. 778 adult patients with in-hospital cardiac arrest receiving at least one dose of adrenaline will be enrolled. The primary o...

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
778
Inclusion Criteria
  1. In-hospital cardiac arrest
  2. Age ≥ 18 years
  3. Received at least one dose of adrenaline during cardiopulmonary resuscitation (CPR)
Read More
Exclusion Criteria
  1. Clearly documented "do-not-resuscitate" order prior to the cardiac arrest
  2. Prior enrollment in the trial
  3. Invasive mechanical circulatory support at the time of the cardiac arrest
  4. Known or suspected pregnancy at the time of the cardiac arrest
  5. Known objection by the patient to participate in the trial
  6. Clinical indication for bicarbonate administration
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sodium bicarbonateSodium bicarbonate50 ml of 1 mmol/ml sodium bicarbonate given as soon as possible after the first dose of adrenaline. If the patient remains in cardiac arrest, one additional dose of 50 ml of 1 mmol/ml sodium bicarbonate will be administered after the second dose of adrenaline dose for a maximum of two doses.
PlaceboSodium chloride50 mL of 9 mg/mL NaCl ("normal saline") given as soon as possible after the first dose of adrenaline. If the patient remains in cardiac arrest, one additional dose of 50 mL of 9 mg/mL NaCl will be administered after the second dose of adrenaline dose for a maximum of two doses.
Primary Outcome Measures
NameTimeMethod
Number of Participants With Return of Spontaneous CirculationDuring the cardiac arrest, an average of 20 minutes

Return of spontaneous circulation is defined as spontaneous circulation with no further need for chest compressions sustained for at least 20 minutes

Secondary Outcome Measures
NameTimeMethod
Number of Participants With a Favorable Neurological Outcome at 30 DaysAt 30 days

A favorable neurological outcome will be defined as a modified Rankin Scale score of 0, 1, 2 or 3. The modified Rankin Scale is a 7-point scale assessing neurological/functional outcomes after brain damage with higher scores indicating worse neurological/functional outcomes.

Number of Participants That Survived 30 DaysAt 30 days

Trial Locations

Locations (22)

Nykøbing Falster Hospital

🇩🇰

Nykøbing Falster, Denmark

Hospital of Southern Jutland - Aabenraa

🇩🇰

Aabenraa, Denmark

Copenhagen University Hospital - Herlev

🇩🇰

Herlev, Denmark

Odense University Hospital - Svendborg

🇩🇰

Svendborg, Denmark

Viborg Regional Hospital

🇩🇰

Viborg, Denmark

Hospital of Southwest Jutland - Esbjerg

🇩🇰

Esbjerg, Denmark

Horsens Regional Hospital

🇩🇰

Horsens, Denmark

Hvidovre Hospital

🇩🇰

Hvidovre, Denmark

Odense University Hospital

🇩🇰

Odense, Denmark

Randers Regional Hospital

🇩🇰

Randers, Denmark

Zealand University Hospital - Roskilde

🇩🇰

Roskilde, Denmark

Slagelse Hospital

🇩🇰

Slagelse, Denmark

Aalborg University Hospital

🇩🇰

Aalborg, Denmark

Aarhus University Hospital

🇩🇰

Aarhus, Denmark

Copenhagen University Hospital - Bispebjerg

🇩🇰

Bispebjerg, Denmark

Copenhagen University Hospital - Rigshospitalet

🇩🇰

Copenhagen, Denmark

Copenhagen University Hospital - Gentofte

🇩🇰

Gentofte, Denmark

Gødstrup Hospital

🇩🇰

Gødstrup, Denmark

Holbæk Hospital

🇩🇰

Holbæk, Denmark

North Denmark Region Hospital - Hjørring

🇩🇰

Hjørring, Denmark

Kolding Hospital

🇩🇰

Kolding, Denmark

Zealand University Hospital - Køge

🇩🇰

Køge, Denmark

© Copyright 2024. All Rights Reserved by MedPath